Home
TYRA
TYRA News

Latest Tyra Biosciences Inc. (TYRA) News on October 15, 2025

Tyra Biosciences Announces Late-Breaking Poster Presentation on TYRA-300 Preclinical Results at ENDO 2025

PR Newswire

3 months ago

Tyra Biosciences Announces Late-Breaking Poster Presentation on TYRA-300 Preclinical Results at ENDO 2025

Tyra Biosciences to Participate at Upcoming Investor Conferences

PR Newswire

5 months ago

Tyra Biosciences to Participate at Upcoming Investor Conferences

One Tyra Biosciences Insider Raised Stake By 284% In Previous Year

Simply Wall St.

5 months ago

One Tyra Biosciences Insider Raised Stake By 284% In Previous Year

Tyra Biosciences Reports First Quarter 2025 Financial Results and Highlights

PR Newswire

5 months ago

Tyra Biosciences Reports First Quarter 2025 Financial Results and Highlights

Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth

Simply Wall St.

7 months ago

Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth

Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights

PR Newswire

7 months ago

Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights

Tyra Biosciences to Present at Upcoming Investor Conferences

PR Newswire

8 months ago

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors

PR Newswire

9 months ago

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors

Private equity firms account for 44% of Tyra Biosciences, Inc.'s (NASDAQ:TYRA) ownership, while institutions account for 33%

Simply Wall St.

9 months ago

Private equity firms account for 44% of Tyra Biosciences, Inc.'s (NASDAQ:TYRA) ownership, while institutions account for 33%

Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium

PR Newswire

9 months ago

Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium

MT Newswires

9 months ago

Tyra Biosciences Insider Sold Shares Worth $409,645, According to a Recent SEC Filing

MT Newswires

9 months ago

Tyra Biosciences' TYRA-300 Gets US FDA Clearance for Phase 2 Trial in Non-Muscle Invasive Bladder Cancer

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)

PR Newswire

9 months ago

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)

Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Simply Wall St.

a year ago

Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Tyra Biosciences to Present at Upcoming Investor Conferences

PR Newswire

a year ago

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights

PR Newswire

a year ago

Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 11/04/2024

Chief Financial Officer of Tyra Biosciences Alan Fuhrman Buys 284% More Shares

Simply Wall St.

a year ago

Chief Financial Officer of Tyra Biosciences Alan Fuhrman Buys 284% More Shares

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301)

PR Newswire

a year ago

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301)

MT Newswires

a year ago

Tyra Biosciences Shares Retreat After Gains Following Positive Clinical Trial Results for TYRA-300

Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC)

PR Newswire

a year ago

Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC)

Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET

PR Newswire

a year ago

Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET

RA Capital Management, L.P. Reduces Stake in Tyra Biosciences Inc

GuruFocus.com

a year ago

RA Capital Management, L.P. Reduces Stake in Tyra Biosciences Inc

MT Newswires

a year ago

Tyra Biosciences Insider Sold Shares Worth $1,711,247, According to a Recent SEC Filing

Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug

Benzinga

a year ago

BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug

MT Newswires

a year ago

BofA Securities Upgrades Tyra Biosciences to Buy From Neutral, Adjusts Price Target to $31 From $22

MT Newswires

a year ago

Tyra Biosciences Insider Sold Shares Worth $1,513,271, According to a Recent SEC Filing

Boxer Capital, LLC Increases Stake in Tyra Biosciences Inc

GuruFocus.com

a year ago

Boxer Capital, LLC Increases Stake in Tyra Biosciences Inc

Tyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024)

PR Newswire

a year ago

Tyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024)

MT Newswires

a year ago

Tyra Biosciences Insider Sold Shares Worth $283,223, According to a Recent SEC Filing

MT Newswires

a year ago

Oppenheimer Adjusts Tyra Biosciences Price Target to $33 From $25, Maintains Outperform Rating

Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference

PR Newswire

a year ago

Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference

MT Newswires

a year ago

Tyra Biosciences Names Doug Warner Chief Medical Officer

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer

PR Newswire

a year ago

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer

Wall Street Analysts Think Tyra Biosciences (TYRA) Could Surge 27.88%: Read This Before Placing a Bet

Zacks

a year ago

Wall Street Analysts Think Tyra Biosciences (TYRA) Could Surge 27.88%: Read This Before Placing a Bet

Tyra Biosciences, Inc. (TYRA): One of Oppenheimer’s Top Stock Picks For the Next 12 Months

Insider Monkey

a year ago

Tyra Biosciences, Inc. (TYRA): One of Oppenheimer’s Top Stock Picks For the Next 12 Months

MT Newswires

a year ago

Piper Sandler Initiates Tyra Biosciences at Overweight With $33 Price Target

MT Newswires

a year ago

Oppenheimer Adjusts Tyra Biosciences Price Target to $25 From $28, Maintains Outperform Rating

Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights

PR Newswire

a year ago

Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights

MT Newswires

a year ago

Tyra Biosciences Plans to Develop Potential Treatment of Dwarfism, File Application in H2

Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH)

PR Newswire

a year ago

Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH)

Does This Valuation Of Tyra Biosciences, Inc. (NASDAQ:TYRA) Imply Investors Are Overpaying?

Simply Wall St.

a year ago

Does This Valuation Of Tyra Biosciences, Inc. (NASDAQ:TYRA) Imply Investors Are Overpaying?

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Tyra Biosciences (TYRA) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

a year ago

Tyra Biosciences (TYRA) Upgraded to Buy: What Does It Mean for the Stock?

Wall Street Analysts See a 27.27% Upside in Tyra Biosciences (TYRA): Can the Stock Really Move This High?

Zacks

a year ago

Wall Street Analysts See a 27.27% Upside in Tyra Biosciences (TYRA): Can the Stock Really Move This High?

Tyra Biosciences to Present at Upcoming Investor Conferences

PR Newswire

a year ago

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

a year ago

Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights

PR Newswire

a year ago

Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights

Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors

PR Newswire

a year ago

Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors

GuruFocus.com

2 years ago

Tyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline Progress

Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights

PR Newswire

2 years ago

Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights

Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 9,152 Shares

GuruFocus.com

2 years ago

Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 9,152 Shares

Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 8,644 Shares

GuruFocus.com

2 years ago

Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 8,644 Shares

Tyra Biosciences to Present at Upcoming Investor Conferences

PR Newswire

2 years ago

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference

PR Newswire

2 years ago

Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference

President and CEO Todd Harris Sells 100,000 Shares of Tyra Biosciences Inc (TYRA)

GuruFocus.com

2 years ago

President and CEO Todd Harris Sells 100,000 Shares of Tyra Biosciences Inc (TYRA)

Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing

PR Newswire

2 years ago

Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing

Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia

PR Newswire

2 years ago

Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia

Petco (WOOF) Unveils Pet Insurance Offering With Nationwide

Zacks

2 years ago

Petco (WOOF) Unveils Pet Insurance Offering With Nationwide

Associated Press Finance

2 years ago

First Community Bancshares: Q4 Earnings Snapshot

First Community Bankshares, Inc. Announces Fourth Quarter 2023 Results and Quarterly Cash Dividend

GlobeNewswire

2 years ago

First Community Bankshares, Inc. Announces Fourth Quarter 2023 Results and Quarterly Cash Dividend

West Fraser (WFG) to Shut Down Its Fraser Lake Sawmill

Zacks

2 years ago

West Fraser (WFG) to Shut Down Its Fraser Lake Sawmill

Petco and Nationwide® launch co-branded pet insurance product on petco.com

PR Newswire

2 years ago

Petco and Nationwide® launch co-branded pet insurance product on petco.com

Insteel Industries Inc (IIIN) Faces Headwinds in Q1 2024 with Net Earnings and Sales Decline

GuruFocus.com

2 years ago

Insteel Industries Inc (IIIN) Faces Headwinds in Q1 2024 with Net Earnings and Sales Decline

Bear of the Day: Petco Health and Wellness Co. (WOOF)

Zacks

2 years ago

Bear of the Day: Petco Health and Wellness Co. (WOOF)

Eventbrite Introduces Instant Payouts and Tap to Pay, a Transformative Duo That Delivers a Win-Win Experience for Event Organizers and Attendees

Business Wire

2 years ago

Eventbrite Introduces Instant Payouts and Tap to Pay, a Transformative Duo That Delivers a Win-Win Experience for Event Organizers and Attendees

A Look Back at Specialty Retail Stocks' Q3 Earnings: Petco (NASDAQ:WOOF) Vs The Rest Of The Pack

StockStory

2 years ago

A Look Back at Specialty Retail Stocks' Q3 Earnings: Petco (NASDAQ:WOOF) Vs The Rest Of The Pack

Omnicell Elects Eileen Voynick to Board of Directors

Business Wire

2 years ago

Omnicell Elects Eileen Voynick to Board of Directors

HCI Group to Redeem 4.25% Convertible Senior Notes

GlobeNewswire

2 years ago

HCI Group to Redeem 4.25% Convertible Senior Notes

GlobeNewswire

2 years ago

iHeartMedia and Magnite Unify Access to Broadcast and Digital Audio, Providing Advertisers with a Direct Path to Premium Inventory

3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts

Motley Fool

2 years ago

3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts

MFA Financial, Inc. Announces Pricing of Public Offering of Senior Notes

Business Wire

2 years ago

MFA Financial, Inc. Announces Pricing of Public Offering of Senior Notes

BJ's Restaurants (BJRI) Stock Declines While Market Improves: Some Information for Investors

Zacks

2 years ago

BJ's Restaurants (BJRI) Stock Declines While Market Improves: Some Information for Investors

ECARX Announces Board Changes

GlobeNewswire

2 years ago

ECARX Announces Board Changes

Introducing the All-New 2024 Malibu 21 LX-r

GlobeNewswire

2 years ago

Introducing the All-New 2024 Malibu 21 LX-r

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study

PR Newswire

2 years ago

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study

Magnite, Inc.'s (NASDAQ:MGNI) recent 6.4% pullback adds to one-year year losses, institutional owners may take drastic measures

Simply Wall St.

2 years ago

Magnite, Inc.'s (NASDAQ:MGNI) recent 6.4% pullback adds to one-year year losses, institutional owners may take drastic measures

Business Wire

2 years ago

Olo to Present at the ICR Conference

2 Biotech Stocks You Can Buy and Hold for the Next Decade

Motley Fool

2 years ago

2 Biotech Stocks You Can Buy and Hold for the Next Decade

Here's Why Beazer Homes (BZH) Fell More Than Broader Market

Zacks

2 years ago

Here's Why Beazer Homes (BZH) Fell More Than Broader Market

U.S. Silica Holdings, Inc. Announces Completion of $25 Million Loan Repurchase

PR Newswire

2 years ago

U.S. Silica Holdings, Inc. Announces Completion of $25 Million Loan Repurchase

16 Most Promising Long-Term Stocks According to Analysts

Insider Monkey

2 years ago

16 Most Promising Long-Term Stocks According to Analysts

Business Wire

2 years ago

Empire State Realty Trust Announces Stock Repurchase Authorization

Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300

PR Newswire

2 years ago

Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300

Cerence Pioneers Automotive-Specific LLM in Collaboration with NVIDIA, Powering the Future of In-Car Experiences

GlobeNewswire

2 years ago

Cerence Pioneers Automotive-Specific LLM in Collaboration with NVIDIA, Powering the Future of In-Car Experiences

Two Harbors Investment Corp. Announces Fourth Quarter 2023 Common and Preferred Stock Dividends

Business Wire

2 years ago

Two Harbors Investment Corp. Announces Fourth Quarter 2023 Common and Preferred Stock Dividends

Business Wire

2 years ago

Waffle House Partners with Olo to Lead First Brand-Wide Digital Investment

Olo Inc.'s (NYSE:OLO) 27% Jump Shows Its Popularity With Investors

Simply Wall St.

2 years ago

Olo Inc.'s (NYSE:OLO) 27% Jump Shows Its Popularity With Investors

Insider Sell Alert: EVP, General Counsel & Sec. ...

GuruFocus.com

2 years ago

Insider Sell Alert: EVP, General Counsel & Sec. ...

Chairman of the Board of Heartland Express Picks Up 1.2% More Stock

Simply Wall St.

2 years ago

Chairman of the Board of Heartland Express Picks Up 1.2% More Stock

Select Water Solutions, Inc. (NYSE:WTTR) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Simply Wall St.

2 years ago

Select Water Solutions, Inc. (NYSE:WTTR) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

14 Low PE High Dividend Stocks to Buy Now

Insider Monkey

2 years ago

14 Low PE High Dividend Stocks to Buy Now

Share on Social Networks: